Pennell D J, Mahmood S, Ell P J, Underwood S R
Nuclear Medicine Department, Royal Brompton National Heart and Lung Hospital, London, UK.
Eur J Nucl Med. 1994 Feb;21(2):170-2. doi: 10.1007/BF00175766.
Adenosine is used increasingly as an alternative to dynamic exercise during myocardial perfusion imaging because it is a powerful coronary vasodilator with a short half-life. Minor side-effects are common but life-threatening events are rare. We report two cases of provocation by adenosine infusion of profound sinus bradycardia progressing to atrial and ventricular asystole. Despite discontinuation of the infusion, asystole persisted for up to 1 min in one case and was accompanied by a grand mal seizure. Normal sinus rhythm returned spontaneously in both cases without long-term sequelae. Sino-atrial disease was later suggested in both cases by 24-h electrocardiographic monitoring. We conclude that patients to whom adenosine is given may have occult sino-atrial disease and may be susceptible to life-threatening arrhythmias. Significant sinus bradycardia during the infusion may provide a warning of its presence.
在心肌灌注成像中,腺苷越来越多地被用作动态运动的替代方法,因为它是一种强大的冠状动脉血管扩张剂,半衰期短。轻微的副作用很常见,但危及生命的事件很少见。我们报告了两例因输注腺苷诱发严重窦性心动过缓并进展为心房和心室停搏的病例。尽管停止了输注,但其中一例停搏持续长达1分钟,并伴有大发作癫痫。两例均自发恢复正常窦性心律,无长期后遗症。后来通过24小时心电图监测提示两例均患有窦房结疾病。我们得出结论,接受腺苷治疗的患者可能患有隐匿性窦房结疾病,并且可能易患危及生命的心律失常。输注过程中出现明显的窦性心动过缓可能提示其存在。